Agitation
📧 Sign up to get email alerts when something new happens for Agitation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy, safety, and tolerability of BMS-986368 for agitation in participants with Alzheimer's d…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II) [Phase 3]
A Phase 3 trial (TRANQUILITY II) evaluating dexmedetomidine for agitation in dementia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation [Phase 3]
Phase 3 study evaluating AXS-05 for agitation in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Doll Therapy for Agitated Elderly Dementia People [NA]
Clinical trial evaluating doll therapy to manage agitation in elderly patients with dementia; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Propofol vs. Nasal Dexmedetomidine in Pediatric Agitation and Delirium [Phase 4]
Phase 4 trial update comparing propofol with nasal dexmedetomidine for pediatric agitation and delirium. Status shows the study is completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-16FDA Approved: HALOPERIDOL LACTATE — Supplemental Application (Mylan Institutional LLC)
FDA granted a supplemental approval for HALOPERIDOL LACTATE to Mylan Institutional LLC, issuing a supplemental application for this generic …
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Acute Agitation in Emergency Psychiatry [Phase 2, Phase 3]
Ongoing Phase 2 and Phase 3 clinical trials evaluating treatments for acute agitation in emergency psychiatry are currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Agitation Follow up After Introduction of a New Patient Care Algorithm
Completed clinical trial evaluating the impact of a new patient care algorithm on agitation and psychomotor agitation. The update summarizes…
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III) [Phase 3]
Phase 3 clinical trial evaluating dexmedetomidine for agitation in dementia was terminated.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia [Phase 1, Phase 2]
Clinical trial update for sub-lingual dexmedetomidine in agitation associated with dementia, spanning Phase 1 and Phase 2; study completed w…
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type [Phase 3]
Phase 3 trial evaluating safety, efficacy, and tolerability of brexpiprazole for agitation in Alzheimer's dementia has completed with result…
-
CLINICAL_TRIALS trial_result · 2023-09-11Clinical Trial Update: The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation [Phase 4]
Phase 4 trial update investigating whether intraoperative magnesium sulfate infusion reduces emergence agitation.
-
CLINICAL_TRIALS trial_result · 2023-08-25Clinical Trial Update: An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia [Phase 2]
Phase 2 trial of BXCL501 for agitation associated with dementia was terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia [Phase 3]
Phase 3 clinical trial evaluating dexmedetomidine for agitation in schizophrenia completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-04-07Clinical Trial Update: A Study of Olanzapine in Patients With Acute Agitation [Phase 3]
A Phase 3 clinical trial evaluating olanzapine for acute agitation is in progress with status not specified.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Intramuscular Ketamine Effect on Postnasal Surgery Agitation [Phase 2]
Phase 2 trial assessing intramuscular ketamine for agitation after nasal surgery has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: IM Olanzapine Versus Haloperidol or Midazolam [Phase 4]
Phase 4 trial comparing intramuscular olanzapine to haloperidol or midazolam for acute agitation; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Oral Olanzapine Versus Haloperidol or Diazepam [Phase 4]
Phase 4 trial comparing oral olanzapine with haloperidol or diazepam for acute agitation and behavioural emergency; study terminated.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting [Phase 4]
Phase 4 trial assessing rapid tranquilisation for agitated patients in psychiatric emergency/aggression settings has completed with posted r…
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Emergence Agitation After Nasal Surgery: a Randomized Controlled Comparison Between Melatonin and Mirtazapine [Phase 4]
Phase 4 randomized trial comparing melatonin versus mirtazapine for emergence agitation after nasal surgery.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Nalbuphine Versus Dexmedetomidine for Prevention of Emergence Agitation in Pediatrics [Phase 4]
Phase 4 trial comparing nalbuphine to dexmedetomidine for prevention of emergence agitation in pediatric patients; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease [Phase 2]
Phase 2 study evaluating AVP-923 (dextromethorphan/quinidine) for agitation in Alzheimer's disease completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-04Clinical Trial Update: Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting [Phase 4]
Phase IV trial evaluating the safety of self-administered ADASUVE in agitated patients outside the hospital setting has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-13Clinical Trial Update: Acupuncture to Improve Comfort of Children on a Ventilator in the Intensive Care Unit [NA]
A completed clinical trial evaluating acupuncture to improve comfort for children on a ventilator in the ICU; results were posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Safety and Efficacy of Nabilone in Alzheimer's Disease [Phase 2, Phase 3]
Clinical trial update on nabilone for Alzheimer's disease evaluating safety and efficacy across Phase 2 and Phase 3.